Ohtuvayre showed significant improvement in lung function by 12 weeks. Follow-up analyses showed that Ohtuvayre had long-term ...

After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

A Midtown-based medical device startup is carving a niche in the growing field of treatments to address chronic lung disease.

Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...

Therapies to treat IPF are limited ... and cellular interactions in distinct cell populations in chronic obstructive pulmonary disease ...

Study AER-01-002 is using a novel and precision imaging strategy to enroll 100 mucus plug-high chronic obstructive pulmonary disease (COPD ... company developing novel inhaled treatments for ...